• 1
    Bolte AC, van Geijn HP, Dekker GA. Pathophysiology of preeclampsia and the role of serotonin: a review. Eur J Obstet Gynaecol 2001;95(1):1221.
  • 2
    Schneider TJ, Struijk PC, Lotgering FK, Wallenburg HCS. Placental transfer and maternal and fetal hemodynamic effects of ketanserin in the pregnant ewe. Eur J Obstet Gynaecol Reprod Biol 1996;68: 179184.
  • 3
    Yassen A, Hanff LM, Vulto AG. Simultaneous quantitative analysis of ketanserin and ketanserinol in plasma by RP-HPLC with fluorescence detectionv. Biomed Chromatogr 2003;17: 517521.
  • 4
    Persson B, Heykants J, Hedner T. Clinical pharmacokinetics of ketanserin. Clin Pharmacokinet 1991;20(4):263279.
  • 5
    Bolte AC, van Geijn HP, Dekker GA. Pharmacological treatment of severe hypertension in pregnancy and the role of serotonine-2 receptor blockers. Eur J Obstet Gynaecol 2001;95(1):2226.
  • 6
    Rossouw HJ, Howarth G, Odendaal HJ. Ketanserin and hydralazine in hypertension in pregnancy—a randomised double-blind trial. S Afr Med J 1995;85(5):525528.
  • 7
    Steyn DW, Odendaal HJ, Kirsten GF. Mental development in children six years after in utero exposure to ketanserin—a follow-up study of a randomized controlled trial. Hypertens Pregnancy 2002;21(Suppl 1):131.